Anesthesia with propofol induces insulin resistance systemically in skeletal and cardiac muscles and liver of rats

作者：Yasuda Yoshikazu; Fukushima Yuji; Kaneki Masao; Martyn J A Jeevendra^*

来源：Biochemical and Biophysical Research Communications, 2013, 431(1): 81-85.

DOI：10.1016/j.bbrc.2012.12.084

• Glucose output (hepatic)
• Hepatic glucose uptake
• Hyperinsulinemic clamp
• Insulin resistance
• Muscle glucose uptake
• Propofol
• Sedation

Hyperglycemia together with hepatic and muscle insulin resistance are common features in critically ill patients, and these changes are associated with enhanced inflammatory response, increased susceptibility to infection, muscle wasting, and worsened prognosis. Tight blood glucose control by intensive insulin treatment may reduce the morbidity and mortality in intensive care units. Although some anesthetics have been shown to cause insulin resistance, it remains unknown how and in which tissues insulin resistance is induced by anesthetics. Moreover, the effects of propofol, a clinically relevant intravenous anesthetic, also used in the intensive care unit for sedation, on insulin sensitivity have not yet been investigated. Euglycemic hyperinsulinemic clamp study was performed in rats anesthetized with propofol and conscious unrestrained rats. To evaluate glucose uptake in tissues and hepatic glucose output [H-3]glucose and 2-deoxy[C-14]glucose were infused during the clamp study. Anesthesia with propofol induced a marked whole-body insulin resistance compared with conscious rats, as reflected by significantly decreased glucose infusion rate to maintain euglycemia. Insulin-stimulated tissue glucose uptake was decreased in skeletal muscle and heart, and hepatic glucose output was increased in propofol anesthetized rats. Anesthesia with propofol induces systemic insulin resistance along with decreases in insulin-stimulated glucose uptake in skeletal and heart muscle and attenuation of the insulin-mediated suppression of hepatic glucose output in rats.

• 出版日期2013-2-1